Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$80.36 - $102.87 $1,607 - $2,057
20 New
20 $1.61 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $1,818 - $2,255
20 New
20 $2.11 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Vermillion & White Wealth Management Group, LLC Portfolio

Follow Vermillion & White Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vermillion & White Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vermillion & White Wealth Management Group, LLC with notifications on news.